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Malaria vector control may be compromised by resistance to
insecticides in vector populations. Actions to mitigate against
resistance rely on surveillance using standard susceptibility tests,
but there are large gaps in the monitoring data across Africa.
Using a published geostatistical ensemble model, we have gener-
ated maps that bridge these gaps and consider the likelihood that
resistance exceeds recommended thresholds. Our results show
that this model provides more accurate next-year predictions than
two simpler approaches. We have used the model to generate
district-level maps for the probability that pyrethroid resistance
in Anopheles gambiae s.l. exceeds the World Health Organization
thresholds for susceptibility and confirmed resistance. In addition,
we have mapped the three criteria for the deployment of piper-
onyl butoxide-treated nets that mitigate against the effects of
metabolic resistance to pyrethroids. This includes a critical review
of the evidence for presence of cytochrome P450-mediated meta-
bolic resistance mechanisms across Africa. The maps for pyrethroid
resistance are available on the IR Mapper website, where they can
be viewed alongside the latest survey data.
pyrethroid | malaria control | insecticide resistance management |
insecticide resistance | metabolic resistance
Malaria control is primarily achieved by targeting the mos-quito vectors that transmit the malaria parasite. In sub-
Saharan Africa, vector control relies heavily on insecticides in-
tegrated into bednets or applied to indoor walls (1). This means
that vector control, and thus malaria control, may be compro-
mised by resistance to these insecticides in vector populations (2).
The World Health Organization (WHO) published a Global
Plan for Insecticide Resistance Management in Malaria Vectors
(hereafter the “Global Plan for IRM”) that outlines best-practice
strategies for preserving or prolonging the effectiveness of the
insecticides used for malaria control, based on the best available
evidence at the time (3). Recommended actions depend on
surveillance of insecticide resistance measured by standard in-
secticide susceptibility tests as summarized in Table 1. These
actions rely on the availability of insecticides with distinct modes
of action that can be either rotated annually, applied in spatial
mosaics, used in combinations of different interventions, or ap-
plied as mixed formulations. For indoor residual spraying (IRS),
four neurotoxic insecticide classes have been used over many
decades (carbamates, organochlorines, organophosphates, and
pyrethroids) and, more recently, a neonicotinoid has also been
approved (4). In contrast, the range of insecticides recommended
for insecticide-treated nets is more restricted and until 2016 was
limited to pyrethroids, either alone or in combination with piperonyl
butoxide (PBO), a synergist that counters P450 cytochrome-mediated
resistance to pyrethroids but does not have an impact in the absence
of this mechanism of resistance.
Long-lasting insecticide-treated nets (LLINs) are the primary
recommended intervention for vector control and the use of
pyrethroid-treated nets has underpinned the reductions in
malaria prevalence from 2000 to 2015 (1, 5). For this reason, the
Global Plan for IRM places particular emphasis on prolonging
the effectiveness of pyrethroids in vector control. All currently
recommended insecticide-treated net formulations use pyre-
throids, but dramatic increases in pyrethroid resistance in the
major African malaria vectors have occurred from 2005 to 2017
(4, 6). Fortunately, three partner compounds have recently been
introduced to net formulations. WHO prequalification status has
been awarded to LLINs impregnated with a combination of the
pyrethroid α-cypermethrin, and the pyrrole chlorfenapyr (7) and
to LLINs impregnated with α-cypermethrin and the insect
growth regulator pyriproxyfen (8). LLINs treated with a pyre-
throid (α-cypermethrin, deltamethrin, or permethrin) in combi-
nation with PBO first became available 10 years ago, and in 2017
the WHO gave pyrethroid‐PBO nets an interim endorsement as
a new vector control class pending further review of the epide-
miological data from randomized control trials (9). The WHO’s
Global Plan for IRM covers the use of alternative insecticide
classes but does not provide guidelines for use of products that
contain a synergist that counters a specific mechanism of resis-
tance. The WHO, therefore, published the Conditions for De-
ployment of Mosquito Nets Treated with a Pyrethroid and Piperonyl
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Butoxide (hereafter the “Conditions for Deployment of PBO-
treated Nets”) in 2017 (10, 11). These guidelines also recom-
mend actions that depend on surveillance of insecticide resis-
tance measured by standard insecticide susceptibility tests
(Table 1).
Although the current recommendations in the Global Plan for
IRM and the Conditions for Deployment of PBO-treated Nets
rely on surveillance of insecticide resistance measured by stan-
dard insecticide susceptibility tests (12, 13), a 2017 review of
implementation of the Global Plan for IRM found monitoring
was inadequate and inconsistent in most settings (14, 15). A
review of the data available today shows that this is still true
(Fig. 1). A total of 1,550 results from standard pyrethroid sus-
ceptibility tests using mosquitoes from the Anopheles gambiae
complex or the Anopheles funestus subgroup are available for
2015 to 2017, from a published database (15). This equates to
data for 362 out of 3,323 malaria-endemic second-order ad-
ministrative divisions (hereafter “districts”); thus, 89% of these
districts did not have surveillance data for these years (Fig. 1A).
The data behind the WHO’s Malaria Threats website are not
available, so the number of data points is unknown, but the gaps
in these data can be visualized (Fig. 1B). The data behind the IR
Mapper website can also be visualized online and the number of
data points available for the same pyrethroid tests from 2015 to
2017 is 1,817 (Fig. 1C).
To address these issues, we propose using the results of a re-
cently developed geostatistical ensemble model that was fitted to
a published series of susceptibility test surveillance data covering
31 African countries and spanning a period of 13 years (6, 15).
The geostatistical ensemble model accounts for noise in the
Table 1. Recommendations regarding insecticide choice for LLINs and IRS
1. What is the primary
intervention currently
in use?
2: What is the resistance status (susceptibility test result)?
Pyrethroid resistant (<90% mortality)
Susceptible (>98% mortality)
No cytochrome P450-
mediated resistance or no
data (<10% increase in
mortality with PBO)
Cytochrome P450-mediated resistance (≥10% increase in
mortality with PBO)
(10–80% mortality without
PBO)
(Mortality without PBO not
10–80%)
LLINs Continue monitoring using
susceptibility tests and, if
cases are increasing, ensure
timely replacement of
worn-out nets and assure
the quality and extent of
LLIN coverage.
In addition to LLINs, introduce
focal IRS in annual
rotations, at least in areas
of greatest concern, and
use nonpyrethroid active
ingredients when they
become available,
providing this does not
compromise coverage.
Consider switching to PBO-
treated LLINs. and/or
introducing focal IRS in
annual rotations, at least in
areas of greatest concern,
and using nonpyrethroid
active ingredients,
providing this does not
compromise coverage.
Introduce focal IRS in annual
rotations, at least in areas
of greatest concern, and
use nonpyrethroid active
ingredients, providing this
does not compromise
coverage.
IRS Preemptive rotation of
insecticide classes with
confirmed susceptibility.
Switch away from current insecticide and rotate alternative compounds.
This is an abridged summary of the recommendations in tables 4 and 5 of the Global Plan for IRM and accompanying text, the thresholds defined in the
WHO’s Test Procedures for Insecticide Resistance Monitoring, and the recommendations outlined in the Conditions for Deployment of PBO-treated Nets (3,
10, 12). The recommendations linked to the presence of kdr mechanisms have been excluded for reasons of brevity and because these are not materially
different from “resistance without mechanism data” or “no cytochrome P450-mediated resistance.” The threshold values for susceptibility test results are
given in parentheses.
Fig. 1. Gaps in the available insecticide resistance surveillance data from standard WHO and CDC tests using the An. gambiae complex and An. funestus
subgroup. (A) Districts with susceptibility test (bioassay) results for 2015 to 2017 from a published susceptibility test dataset that collated data from routine
monitoring by agencies such as the President’s Malaria Initiative (PMI) and from research groups in Africa and was subject to rigorous quality-assurance
processes (15). Ninety-four percent (3,136/3,323) of malaria-endemic second-order administrative divisions do not have any data for insecticide resistance in
this year and 89% (2,962/3,323) do not have any data in this year or the two preceding years. (B) Data shown on the WHO Malaria Threats website for the
years 2015 to 2019 (accessed 9 December 2019) (16). (C) Data shown on the IR Mapper website for the years 2015 to 2019 (accessed 9 December 2019)
obtained from published articles and PMI surveillance (17).
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susceptibility test data and provides a set of 13 fine-resolution,
annual maps for each year from 2005 to 2017, representing the
mean prevalence of resistance in An. gambiae s.l. to each of the
pyrethroids most commonly used in LLINs (α-cypermethrin,
deltamethrin, permethrin, and λ-cyhalothrin) and resistance to
DDT. These maps provide values in data-sparse areas and are
potentially a powerful tool for use when considering the choice
of insecticide for malaria vector control. In addition to gaps in
the surveillance data, decision makers are often faced with data
that are not up-to-date (Fig. 1). Here we demonstrate the ca-
pacity of the geostatistical ensemble model to predict pyrethroid
resistance 1 year ahead, outperforming simple district-level data
summaries. Tools for decision makers need to incorporate
threshold values that are linked to specific actions (Table 1) and
provide information about the uncertainty around the predic-
tions for achieving these thresholds. We demonstrate how the
published geostatistical ensemble model can be used to calculate
the probability of these thresholds’ being met. In addition to the
key insecticide susceptibility thresholds defined by resistance
management plans, the deployment of PBO-treated nets re-
quires evidence for the presence cytochrome P450-mediated
mechanisms of resistance (Table 1) (10). Here we therefore
also review and map the evidence for presence of these mech-
anisms of resistance. Finally, we present a set of maps that show
the probability of exceeding thresholds linked to recommended
actions at a district scale, that is, the spatial resolution commonly
used for operational decisions.
Materials and Methods
Identifying Gaps in the Surveillance Data. Standard susceptibility test data for
pyrethroid resistance in all African malaria vectors were extracted from the
largest publicly available database of insecticide resistance data (15) and
processed in QGIS 3.4.12 software. Each data point was linked to a year and
to either the geographical coordinates for a precise collection location or an
identifier for the administrative unit where the mosquitoes were collected.
These two pieces of information were used to calculate the number of data
points in each year in each second-order administrative unit (hereafter re-
ferred to as districts). Each district was also classified as malaria-endemic or
not by overlaying the administrative unit layer with raster maps of Plas-
modium falciparum and Plasmodium vivax. Nonendemic areas were dis-
carded and the proportion of endemic districts with susceptibility test data
for each year was calculated. The resulting map is presented alongside the
most recent data from the IR Mapper and Malaria Threats websites (16, 17).
Existing Geostatistical Ensemble Model Used in This Study. This study used the
outputs from a published Bayesian geostatistical ensemble model (6), which
were used here to generate the cumulative probability maps described be-
low. Further, the model was rerun to test its ability to provide next-year
predictions. The ensemble model has been described in full by Hancock
et al. (6). Briefly, the Bayesian geostatistical ensemble model was fitted to
over 6,000 data points from susceptibility tests that exposed An. gambiae s.l.
mosquitoes to four pyrethroids and DDT. The model leveraged 1) associa-
tions between resistance and potential explanatory variables such as LLIN
coverage, IRS coverage, and agriculture (18–20) and 2) spatial patterns in the
resistance data. This ensemble model generated a posterior distribution of
predictions for every cell in a fine resolution (2.5 arcmin, ∼5-km) grid. Vali-
dation of the outputs by Hancock et al. (6) using withheld data (out-of-
sample validation) showed that the ensemble model produced robust pre-
dictions within the area and time frame for which data on pyrethroid re-
sistance were available. For the current study we used the model output for
mortality after deltamethrin exposure in a standard susceptibility test. We
selected deltamethrin resistance because this pyrethroid has the largest
volume of susceptibility test data available, and the deltamethrin resistance
outputs had the narrowest credible intervals (6). There are, however, strong
associations among the patterns of resistance to all four pyrethroids
(α-cypermethrin, deltamethrin, permethrin, and λ-cyhalothrin) (21).
Calculating District-Level Resistance Means. To generate maps of mean
mortality across each district, mDJ , we used the mean values produced by the
model for every grid cell, weighted using values for An. gambiae s.l. habitat
suitability that are available at the same resolution of ∼5 km as the
resistance values (22):
mDJ =∑
i∈J
mDiJwiJ , [1]
where mDiJ is the predicted mean mortality for deltamethrin in grid cell i and
wiJ is relative habitat suitability.
Calculating the Probability of a District Exceeding a Set Mortality Threshold.
We created a series of maps for the probability of meeting the resistance
thresholds used in management decision making (Table 1) at the district
level. We used the full posterior distributions of resistance predictions made
by the geostatistical ensemble model to produce maps of 1) the probability
that the mean mortality was ≥98% (the WHO threshold for “susceptibility)
and 2) the probability that the mean mortality was <90% (the WHO
threshold for “resistance”).
The posterior distribution of the weighted district mean (Eq. 2) was cal-
culated using k = 1,000 draws from the posterior distribution of the pre-
dicted resistance in each pixel, mDiJk, and then calculating a weighted mean,
mDJk, across each district for each posterior draw:
mDJk =∑
i∈J
mDiJkwiJ . [2]
The cumulative probabilities 1 and 2 across all posterior draws were then
calculated. A wider range of thresholds is useful to visualize the areas worst
affected by resistance so we also calculated the cumulative probabilities that
each district has a mean mortality of <80%, <70%, <60%, <50%, <40%,
<30%, <20%, and <10%.
Assessing Whether the Criteria for Deployment of PBO-Treated Nets Have Been
Met. Deployment of pyrethroid LLINs treated with PBO is currently recom-
mended in places that meet all of the following criteria: 1) there is pyrethroid
resistance that 2) results in 10 to 80%mortality in a susceptibility test and 3) is
conferred (at least in part) by a monooxygenase-based resistance mechanism
(that is, elevated levels of cytochrome P450) (10). To test which districts meet
the first two criteria, we used the full posterior distributions of predictions to
calculate the probability of the mean mortality being 10 to 80% for each
district, as described above for the 98% and 90% threshold maps.
To assess the third criterion, results of paired standard pyrethroid sus-
ceptibility tests conducted from 2005 to 2018 with and without PBO were
extracted from a published database (15). The WHO protocol for these tests
defines a difference of ≥10% as evidence for the presence of cytochrome
P450-mediated mechanisms of resistance (12). The mortality obtained with
the addition of the synergist was plotted against mortality after exposure to
the pyrethroid alone, and the data were divided into those pairs with a
difference of ≥10% mortality and those with a difference of <10% mor-
tality. Each data point had a link to geographical coordinates for the loca-
tion of mosquito collection and these were used to associate each data point
with a second-order administrative unit using the QGIS 3.4.12 software. We
used these data to generate a map that classified each district tested
according to whether it had evidence for presence of this mechanism, or for
its absence, or no evidence. In some instances, more than one data point was
linked to a single district. If a single district had a test result(s) that showed
the presence of this mechanism, as well as a test result(s) that showed an
absence of this mechanism, then the district was classified as having evi-
dence for the presence of cytochrome P450-mediated mechanisms of
resistance.
Assessing the Approaches to Address the Time Lag between Vector Sampling
and Data Availability. One limitation of the available information on resis-
tance, whether it consists of susceptibility test data or modeled predictions
for mean test results, is the time lag between 1) mosquito specimens being
collected in the field and tested for resistance, and 2) the data being checked,
compiled, and made available. The most up-to-date information available is
inevitably out-of-date once it has been cleaned and collated (Fig. 1), but
decision makers require information on the current situation. To address the
scenario where susceptibility test data and modeled maps are available for
each year up to and including the preceding year, but no information is
available for the current year, we tested three approaches to determine
which provides the most robust values for the current year. To do this, we
compared our pyrethroid resistance maps to the observed mortality values
1 year ahead. We also compared the values obtained using two simpler
methods to the observed mortality values 1 year ahead. The two simpler
Moyes et al. PNAS Latest Articles | 3 of 9
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methods involved calculating 1) the mean and 2) the minimum value of the
susceptibility test results from the preceding year for each district. The
minimum mortality value equates to the maximum prevalence of resistance;
thus, in this approach, we assume that mortality is decreasing over time, that
is, resistance is increasing. Each of these three approaches uses susceptibility
test data from vector populations collected in the preceding year(s).
We assessed accuracy using next-year out-of-sample validation. For ex-
ample, we used the geostatistical ensemble modeling approach described in
Hancock et al. (6) to predict resistance based on a subset of the susceptibility
test data spanning the time period 2010 to 2014, and compared the pre-
dictions for 2014 to the withheld test data available for 2015. Similarly,
values for 2015 and 2016 were generated using models fitted to data subsets
spanning the time periods 2010 to 2015 and 2010 to 2016 then compared to
the observed data for 2016 and 2017, respectively. For values calculated
using simpler district-level data summaries, we produced summaries of the
susceptibility test data available for each district for the current year (2014,
2015, and 2016 individually) and then compared these to the next-year
observed values for 2015, 2016, and 2017, respectively.
We compared the root-mean-square error (RMSE) across each of the three
methods, for each of the three years predicted, for each geographical region
(west and east Africa) to give six comparisons of predictive performance.
The geostatistical ensemble model also has the advantage of being able to
provide modeled resistance values for districts in which no susceptibility test
data for the current year are available. We calculated additional RMSE values
comparing the modeled values for districts lacking current-year data with the
next-year observed data for the same three pairs of consecutive years
described above.
Overlaying the Geographical Distributions of An. gambiae s.l. and An. funestus.
The model described above predicted resistance in An. gambiae s.l. and this
complex includes three widespread and important malaria vector species
(Anopheles arabiensis, Anopheles coluzzii, and An. gambiae); however, An.
funestus is also among the most important malaria vector species in Africa.
When used in decision making, the model results generated by this study
need to be considered alongside the respective distributions of the An.
gambiae complex and An. funestus. To produce a single map of their re-
spective distributions, predictive maps of the relative probability of occur-
rence of An. gambiae s.l. and An. funestus produced by Wiebe et al. (22)
were converted to binary maps of presence and absence. The threshold
predicted value from the An. gambiae s.l. map that captured 95% of the
confirmed An. gambiae s.l. occurrences was identified and used to convert
the continuous value maps into binary versions. The value of 95% of con-
firmed reports was selected to allow for errors in the confirmed reports,
including errors in geopositioning of sites and errors in species identifica-
tion. This process was repeated to generate a binary An. funestus map. The
two binary data layers were then overlaid to provide a single map showing
where both An. gambiae s.l. and An. funestus are likely to occur.
Results
Mapping the Probability of Districts Exceeding a Set Mortality
Threshold. We provide a set of four district-level maps to assist
decision makers in assessing pyrethroid resistance levels and
evaluating each district with respect to the resistance thresholds
stated in policy guidelines (Fig. 2). The four maps are the
weighted mean resistance to deltamethrin for each district
(Fig. 2A), the minimummortality value (maximum resistance value)
within each district (Fig. 2B), the probability of mortality to delta-
methrin exceeding the WHO threshold for susceptibility (Fig. 2C),
and the probability of mortality to deltamethrin exceeding the
WHO threshold for confirmed resistance (Fig. 2D). Uncertainty in
the district-level weighted means results from 1) heterogeneity in
resistance within a district and 2) uncertainty in the model predic-
tions for each location within the district. The map of minimum
mortality values (Fig. 2B) provides an alternative summary statistic
derived from the range of values predicted for locations across a
district. In addition, we provide maps showing 1) heterogeneity in
predicted mean mortality within each district and 2) uncertainty
(95% credible intervals) in these predictions for west (SI Appendix,
Fig. S1) and east Africa (SI Appendix, Fig. S2).
Published guidelines for insecticide resistance management pro-
vide clear threshold mortality values linked to recommended ac-
tions, but do not provide guidance on how to handle heterogeneity
within an area or uncertainty associated with either noisy field data
or modeled predictions. While it is essential that uncertainty in
district-level values is considered, viewing two or three or four maps
alongside one another does not make decision making easy. For
these reasons, we used the full set of predictions for every location
within each district to calculate the probability of exceeding the
published thresholds and generate a single map that communicates
both the level of resistance and uncertainty in this value. The
highest and lowest probability values, close to either 0 or 1, indicate
certainty whereas intermediate probabilities, close to 0.5, indicate
uncertainty (Fig. 2 C andD). The results show that the threshold for
susceptibility is highly unlikely to be met in any district in west or
northeast Africa in 2017, but some districts in southern east Africa
had probabilities of greater than 0.5 for meeting the susceptibility
threshold (Fig. 2C). The threshold for confirmed resistance was
highly likely to be met in most districts in west Africa in 2017, al-
though some districts had an intermediate probability (Fig. 2D). In
southern east Africa there was an intermediate or low probability of
confirmed resistance.
These maps show resistance in the An. gambiae species com-
plex and the distribution of this complex is shown in Fig. 3
alongside the predicted distribution for An. funestus. The results
shown in Fig. 2 are relevant in all districts where An. gambiae s.l.
is present, but in areas where An. funestus is also present
(Fig. 3C) the results presented here should be considered
alongside data on resistance in An. funestus.
The published threshold values that are linked to defined ac-
tions may change as new evidence becomes available. In addi-
tion, different thresholds may be selected where resources for
more expensive interventions are limited, meaning that they can
only be deployed in the worst-affected areas. For these reasons,
maps for thresholds at every 10% interval were also generated
and Movie S1 shows the probability of the mean mortality for a
district being below each threshold value from 90 to 10%
mortality.
Assessing Whether the Criteria for Deployment of PBO-Treated Nets
Have Been Met. Deployment of pyrethroid LLINs treated with
PBO is currently recommended in places that meet all of the
following criteria: 1) there is pyrethroid resistance that 2) results
in 10 to 80% mortality in a susceptibility test and 3) is conferred
(at least in part) by a monooxygenase-based resistance mecha-
nism (this is, elevated levels of cytochrome P450), providing
deployment does not compromise the levels of LLIN coverage
that are achieved (10). The predicted probability that district-
level mortality after deltamethrin exposure is 10 to 80% shows
that deployment of these nets would currently be recommended
in much of west and northeast Africa if cytochrome P450-
mediated mechanisms of resistance were confirmed in these
districts (Fig. 4A). Data for the presence of these mechanisms
[defined by WHO in note i of figure 3.1 of the 2016 test pro-
cedures as a ≥10% increase in susceptibility test mortality after
the addition of PBO (12)] show that 79% (276/351) of the sur-
veillance data for An. gambiae s.l. confirms the presence of these
mechanisms, as does 94% (34/36) of the data for An. funestus.
All 20 countries that were tested had evidence of elevated cy-
tochrome P450 and the most recent evidence within each
country was always for presence. The most recent year tested for
these countries ranged from 2009 to 2018. When these data are
plotted geographically, no obvious geospatial trends are appar-
ent (Fig. 4B). It is also clear that there is variation in the increase
achieved when PBO is used, from 10 to 100%, and considerable
noise in the data (Fig. 4C).
There are substantial gaps in the susceptibility test data for
cytochrome P450-mediated pyrethroid , with 96% (3,200/3,323)
of malaria-endemic districts having no data in any year. Of the
districts with data, 92% (114/123) meet the criteria for confirmed
cytochrome P450-mediated pyrethroid resistance and 8% of the
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districts tested had no results that met these criteria. It is worth
noting that 41 districts had multiple test results that gave con-
flicting outcomes of both greater than (presence) and less than
(absence) 10% increase in mortality with the addition of PBO.
That is, the majority of districts (41/50) with one or more test
results that did not meet the criteria to confirm cytochrome
P450-mediated pyrethroid resistance also had a test result that
did meet the criteria. This may indicate variation within district,
Fig. 2. District-level deltamethrin resistance in local An. gambiae s.l. populations. (A) Predicted mean susceptibility test mortality for each district in 2017. (B)
Predicted minimum susceptibility test mortality for each district in 2017. (C) Probability that mean susceptibility test mortality for the district is >98%, the
definition of a “susceptible” population. (D) Probability that mean susceptibility test mortality for the district is <90%, the definition of a “resistant”
population (22).
Fig. 3. The respective distributions of An.gambiae s.l. and An. funestus. (A) The predicted distribution of An. gambiae s.l. taken from Wiebe et al. (22). (B)
The predicted distribution of An. funestus taken from Wiebe et al. (22). (C) The overlap in predicted presence (binary values) of An.gambiae s.l. and
An. funestus.
Moyes et al. PNAS Latest Articles | 5 of 9
A
PP
LI
ED
BI
O
LO
G
IC
A
L
SC
IE
N
CE
S
D
ow
nl
oa
de
d 
by
 g
ue
st
 o
n 
Au
gu
st
 2
7,
 2
02
0 
noise in the test data, or rapid spread of this mechanism of re-
sistance. Either way, there is clearly little definitive evidence for
absence of elevated cytochrome P450 in any of the regions tested.
Collectively these results show that much of west Africa is
likely to have a level of pyrethroid resistance that meets two of
the deployment criteria. Most of these districts do not have cy-
tochrome P450 mechanism data; however, the closest data point
to each district generally indicates presence of this mechanism.
The area of northeast Africa with a high probability of meeting
the criteria for the level of pyrethroid resistance has insufficient
data to comment on whether elevated cytochrome P450 occurs.
Assessing Approaches to Address the Time Lag between Vector Sampling
and Data Availability. The geostatistical ensemble model performed
best according to the out-of-sample RMSE across the 3 years for
both the west and east regions (Table 2). Using the mean of the
values from the preceding year was considerably more accurate in
predicting next-year observations than using the minimum value
across the district in the preceding year.
We also compared values produced by the geostatistical en-
semble model for the current year, in districts that had no test
results in that year, to the observed data for the next year. The
out-of-sample RMSE values obtained overlap with those obtained
across districts that did have susceptibility test data available for
the preceding year (Table 2).
These results demonstrate that predictions from the geo-
statistical ensemble model provide more reliable up-to-date es-
timates of resistance 1 year after data collection compared to
predictions from simple district-level data summaries, and can
predict mortality in districts where no recent susceptibility test
data are available.
Dissemination. The stratified maps presented here and the fine
resolution mean mortality maps from Hancock et al. (6) for the
years 2005 to 2017 are available to view and download on the IR
Mapper website. These maps can be viewed on the IR Mapper
website alongside the susceptibility test results for the years
closest to that being modeled. Users can also choose to view each
of these maps overlaid with the most recent data for both An.
gambiae s.l. and An. funestus, as well as other vectors. They can
zoom into their geographic region of interest and export the map
image they have constructed.
IR Mapper is currently supported by a net manufacturer,
Vestergaard SA, and the data in IR Mapper are managed
through a partnership with the Kenya Medical Research Insti-
tute. This study did not use IR Mapper data for the work
Fig. 4. The probability of meeting the criteria for the deployment of PBO-treated nets. (A) The predicted probability that the mean mortality for a district is
10 to 80%. (B) Districts with surveillance data from paired standard susceptibility tests using a pyrethroid with and without the synergist PBO. (C) Plot of
surveillance data from paired standard susceptibility tests using a pyrethroid with and without the synergist PBO showing the full variation in the results and
key thresholds defined in WHO guidelines.
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described in Materials and Methods and Results; however, data
from both IR Mapper and WHO are presented in the Intro-
duction, alongside the published data that we used in this study,
to illustrate the gaps in the available insecticide resistance data
whatever source is used.
The data files behind the stratified maps constructed during
this study are also available from Figshare (https://doi.org/10.
6084/m9.figshare.12435248).
Discussion
Here we provide maps that show the probability that the mean
prevalence of pyrethroid resistance in a district meets a set of
thresholds linked to specific malaria vector control recommen-
dations. This information has not previously been provided for
regions with data gaps in space and time. Assessing the level of
insecticide resistance is essential in order to prioritize use of
products that mitigate against it (7, 8, 23, 24). The new mixed
formulation malaria vector control products are more expensive
to produce, and funds for malaria control are limited. Past ex-
perience with IRS has shown that a switch to a more expensive
product can reduce the coverage achieved, and reductions in IRS
coverage have been linked to resurgences in malaria (25). It is
therefore vital to have information such as the maps presented
here that aids decisions on when and where more expensive
products that mitigate against insecticide resistance are deployed
(26, 27). The geostatistical ensemble model that we used has
previously been shown to provide robust estimates within the
area and time frame for which sparse data on pyrethroid resis-
tance are available (6). Here we have shown that it provides the
most robust predictions for the next year, in a scenario where no
data for that year are available, compared to taking the mean or
minimum value of the surveillance data for the preceding year.
Similar results were also obtained when no data were available
for the preceding year either. These results indicate that this
approach can, in part, mitigate for the issue of a time lag between
vector sampling and data being available, for instances where
the lag is up to 1 year. This approach will become less robust
the longer the time lag is and the geostatistical ensemble
model cannot compensate for a lack of continued field data
collection (28).
Susceptibility test data are noisy (29, 30) and the low data
volumes typically seen in resistance monitoring (Fig. 1) are
particularly susceptible to issues of data noise. The model used
here has the advantage that it separates the signal (trends in
space and time) from this noise to provide mean mortality val-
ues, and this also has a smoothing effect seen in the fine reso-
lution maps generated by Hancock et al. (6). The maps
presented here were smoothed further by generating a set of
district-wide means, and further still by setting a threshold
mortality value. This results in contiguous areas that have the
same resistance classification and do not always match the var-
iation seen in the raw surveillance data, which may be the result
of issues with sparse data and underlying data noise (31).
The maps presented here show the probability of resistance to
deltamethrin in the An. gambiae species complex at a district
level. The data that went into these maps were from mosquito
samples representative of the An. gambiae species complex at
each time and place, and thus the maps represent resistance in
the species complex at each time and place including variation
caused by the combination of spatially varying species composi-
tion and differences in resistance among these species (6, 15).
Other species are important, notably An. funestus (32–34), and
use of these maps needs to be accompanied by knowledge of the
locally important vectors. Ideally, decisions made using infor-
mation on resistance in An. gambiae s.l. should also be informed
by information on the relative abundance of An. gambiae s.l. and
An. funestus, and any other locally important vectors. The rela-
tive abundance of these vectors has been mapped across Africa
by a previous study, which showed that insecticide-treated net
and IRS use affect the relative abundance of these species (35).
Table 2. Comparing the accuracy of next-year predictions
Next year
RMSE
Ensemble model fit to surveillance data up
to preceding year
Mean value of surveillance data
from preceding year
Minimum value of surveillance data
from preceding year
Data available in
preceding year
West region
2015 0.224 (n = 149) 0.232 (n = 149) 0.386 (n = 149)
2016 0.239 (n = 129) 0.276 (n = 129) 0.309 (n = 129)
2017 0.302 (n = 243) 0.384 (n = 243) 0.50 (n = 243)
East region
2015 0.186 (n = 159) 0.194 (n = 159) 0.301 (n = 159)
2016 0.276 (n = 85) 0.281 (n = 85) 0.298 (n = 85)
2017 0.277 (n = 68) 0.323 (n = 68) 0.395 (n = 68)
Data not available in
preceding year
West region
2015 0.315 (n = 93) No data No data
2016 0.327 (n = 102) No data No data
2017 No data No data No data
East region
2015 0.218 (n = 88) No data No data
2016 0.270 (n = 70) No data No data
2017 0.289 (n = 75) No data No data
The RMSE of predicted and observed next-year resistance where all data obtained after the given year were withheld from the prediction methods. A
lower RMSE indicates a more accurate prediction. Observed datasets consisted of all pyrethroid susceptibility test results (performed using α-cypermethrin,
deltamethrin, permethrin, and λ-cyhalothrin) from the next year for districts where test results for the preceding year were available. n is the number of
withheld data points. The RMSE values shown in bold indicate the best-performing model for each year where multiple options are presented.
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Variation in the behavior of these vectors also influences how
likely it is that they come into contact with indoors, insecticide-
based interventions and, ideally, this variable should also be
considered alongside insecticide resistance (36–39).
The maps presented here also focused on a single pyrethroid,
deltamethrin. Predictions are available for α-cypermethrin, per-
methrin, and λ-cyhalothrin, and maps showing the probability of
meeting key thresholds can also be generated for these pyre-
throids. It is, however, important to note that previous work has
shown strong associations among patterns of resistance to these
four insecticides and evidence of resistance to one is likely to
indicate resistance to the others (21). District-level maps of re-
sistance were chosen to match the spatial resolution currently
commonly used for operational decisions, but finer-resolution
data may increasingly be used by decision makers in the future
and the probability maps presented here can be generated down
to a ∼5-km resolution.
Recommendations for the deployment of PBO-treated nets
are based on evidence for the mechanism of resistance as well as
the level of resistance indicated by susceptibility tests (11). The
most commonly available standardized data for cytochrome
P450-mediated mechanisms of resistance are susceptibility tests
using the PBO synergist (15, 40). More data would be required to
generate predictive maps from synergist test results; however, the
data review presented here poses the question of whether the
benefit of having comprehensive synergist surveillance data are
worth the cost of collecting such data. Here we have shown that
the vast majority of locations tested are classified as having cy-
tochrome P450-mediated pyrethroid resistance, as currently de-
fined by WHO using synergist bioassays (12). Biochemical tests
are also available, but they do not perform consistently. Genetic
tests give more robust results but are expensive to perform and
data are therefore even more sparse. The data that are available
from genetic tests do, however, show the same trends as seen for
the synergist bioassay results (40).
The Malaria Threats website also presents evidence for
whether the criteria for deployment of PBO-treated nets have
been met. On this website, data of unknown collection date are
presented at point locations, rather than districts, although the
locations shown may include centroids of districts and provinces
as well as precisely located sampling sites. Each location is cat-
egorized as either 1) all criteria met, 2) at least one criterion is
not met, or 3) more data are needed. Presumably class 2 includes
instances where either pyrethroid mortality is <10% or >80%, or
where an absence of cytochrome P450-mediated mechanisms of
resistance has been confirmed, although we have shown here
that evidence for absence of this mechanism is often contra-
dicted by evidence for presence. The majority of locations shown
on the Malaria Threats website, viewed on 1 June 2020, were
classified as “more data needed,” again highlighting the gaps in
the available data (SI Appendix, Fig. S3). The Malaria Threats
site shows class 1 locations are most common in west Africa and
least common in the southern part of east Africa, in agreement
with our results. The two approaches may not, however, always
provide consistent results in the future, which highlights the
importance of sharing the data used by both approaches, with
full details of the data sources, so that contradictory results can
be interrogated (15, 41).
As new evidence becomes available, many of the key defini-
tions and thresholds that are currently recommended by the
Global Plan for IRM and the Conditions for Deployment of
PBO-treated Nets may be updated. The results here provide
examples based on the currently recommended threshold values;
however, the approach taken by our study is flexible and SI
Appendix provides maps that use a full range of mortality
thresholds. In addition, current policies advise that if financial
constraints mean that the guidelines cannot be followed without
compromising intervention coverage then the worst-affected
areas should be targeted. Our mean and minimum predictive
value maps (Fig. 2 A and B), the sliding scale of mortality
thresholds (SI Appendix), and the continuous scale of probabil-
ities for defined thresholds (Fig. 2 C and D and SI Appendix) all
allow users to identify such areas.
The current results are of relevance in areas where IRS is the
primary intervention. In these areas, the Global Plan for IRM
also recommends preemptive use of rotations regardless of
available data on insecticide resistance but warns against making
a change if it would result in reduced coverage. The cheapest
insecticides are currently pyrethroids and DDT; however, cross-
resistance between these two classes means that use of one can
lead to resistance to the other, reducing the classes available for
rotation. This means that a rotation of classes that avoids issues
of pyrethroid resistance requires more expensive compounds.
Despite well-reported increases in insecticide resistance, the
practice of using the same insecticide class for IRS in consecutive
years is still common (20). The results presented here allow
groups that are deploying IRS to identify areas where pyrethroid
resistance is highest to target focal use of rotations using more
expensive insecticides. The same approach can be taken in areas
that primarily rely on LLINs, to introduce focal IRS or LLINs
treated with a nonpyrethroid active ingredient, in areas with the
highest resistance.
Ultimately, decisions on which intervention to use, and which
insecticide to select if applicable, depend on multiple entomo-
logical, ecological, economic, epidemiological, cultural, and op-
erational considerations (3). Future work should address this
complexity using a hierarchal decision tree-based system, to
simplify and standardize evidence-based decision making. Evi-
dence of insecticide resistance and an increase in malaria cases
are particularly important considerations for any such decision
tree. Here we have focused on the prevalence of insecticide re-
sistance and provide maps that can be used within a broader
decision-making framework. The results generated by this study
are freely available for use by all groups as stand-alone tools via
the IR Mapper website or they can be obtained from Figshare
for integration into more complex decision-making tools.
Data Availability. The data generated by this study have been de-
posited at Figshare, https://doi.org/10.6084/m9.figshare.12435248.
The data that we used in our analyses were previously released at
Figshare, https://doi.org/10.6084/m9.figshare.9912623, and the Dryad
Digital Repository, https://doi.org/10.5061/dryad.dn4676s.
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